Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

0.702

Today's Change

-0.004 (0.56%)

Day's Change

0.685 - 0.717

Trading Volume

1,222,581

Overview

Market Cap

253 Million

Shares Outstanding

361 Million

Avg Volume

4,612,467

Avg Price (50 Days)

0.92

Avg Price (200 Days)

1.58

PE Ratio

-0.95

EPS

-0.74

Earnings Announcement

10-Mar-2025

Previous Close

0.71

Open

0.71

Day's Range

0.685 - 0.7167

Year Range

0.62 - 3.73

Trading Volume

1,222,581

Price Change Highlight

1 Day Change

-0.55%

5 Day Change

-16.44%

1 Month Change

-13.38%

3 Month Change

-60.79%

6 Month Change

-64.55%

Ytd Change

-9.68%

1 Year Change

-46.83%

3 Year Change

-79.66%

5 Year Change

-83.13%

10 Year Change

-90.07%

Max Change

-99.47%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment